ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,205.11
0.17%
Dow Jones
38,834.86
0.15%
Gold vs US Dollar
2,328.31
0.34%
Brent Oil
84.695
-0.11%
Bitcoin
64,819.96
-0.49%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Avalo Therapeutics Inc (AVTX)

  7. Avalo Therapeutics Inc (AVTX) News

Avalo Therapeutics (AVTX)

Avalo Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AVTX
DateTimeSourceHeadlineSymbolCompany
17/06/202412:30GlobeNewswire Inc.Avalo to Present at the Oppenheimer Novel Targets in Immunology SummitNASDAQ:AVTXAvalo Therapeutics Inc
07/06/202412:01Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AVTXAvalo Therapeutics Inc
06/06/202421:03Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:AVTXAvalo Therapeutics Inc
03/06/202412:20Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:AVTXAvalo Therapeutics Inc
23/05/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTXAvalo Therapeutics Inc
13/05/202417:38Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AVTXAvalo Therapeutics Inc
13/05/202412:33Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVTXAvalo Therapeutics Inc
13/05/202412:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTXAvalo Therapeutics Inc
13/05/202412:30GlobeNewswire Inc.Avalo Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:AVTXAvalo Therapeutics Inc
02/04/202412:00GlobeNewswire Inc.Avalo Therapeutics Appoints Biotech Leaders to Board of DirectorsNASDAQ:AVTXAvalo Therapeutics Inc
29/03/202420:01GlobeNewswire Inc.Avalo Reports 2023 Financial Results and Provides Business UpdatesNASDAQ:AVTXAvalo Therapeutics Inc
27/03/202420:01GlobeNewswire Inc.Avalo Acquires Anti-IL-1β mAb and Announces Private Placement Financing of up to $185 MillionNASDAQ:AVTXAvalo Therapeutics Inc
15/02/202402:13Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AVTXAvalo Therapeutics Inc
14/02/202415:02Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AVTXAvalo Therapeutics Inc
31/01/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTXAvalo Therapeutics Inc
28/12/202322:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTXAvalo Therapeutics Inc
27/12/202312:00GlobeNewswire Inc.Avalo Therapeutics Announces 1-for-240 Reverse Stock SplitNASDAQ:AVTXAvalo Therapeutics Inc
21/12/202321:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTXAvalo Therapeutics Inc
21/12/202321:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVTXAvalo Therapeutics Inc
20/12/202321:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTXAvalo Therapeutics Inc
07/12/202312:02Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AVTXAvalo Therapeutics Inc
07/12/202312:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTXAvalo Therapeutics Inc
07/12/202312:00GlobeNewswire Inc.Avalo Encourages Stockholders to Vote FOR the Reverse Stock SplitNASDAQ:AVTXAvalo Therapeutics Inc
16/11/202312:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTXAvalo Therapeutics Inc
09/11/202312:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVTXAvalo Therapeutics Inc
09/11/202312:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTXAvalo Therapeutics Inc
09/11/202312:00GlobeNewswire Inc.Avalo Reports Third Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:AVTXAvalo Therapeutics Inc
31/10/202311:21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVTXAvalo Therapeutics Inc
31/10/202311:00GlobeNewswire Inc.Avalo Completes Divestiture of AVTX-800 SeriesNASDAQ:AVTXAvalo Therapeutics Inc
19/10/202321:15Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AVTXAvalo Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:AVTX

Your Recent History

LSE
GDR
Genedrive
LSE
AAZ
Anglo Asian Mining
LSE
PANR
Pantheon Resources
LSE
ENET
Ethernity Networks
LSE
BIRD
Blackbird
LSE
QBT
Quantum Blockchain Techn...
LSE
AXL
Arrow Exploration
LSE
THG
Thg
LSE
GCM
Gcm Resources
LSE
LLOY
Lloyds Banking
LSE
POS
Plexus
LSE
SCE
Surface Transforms
LSE
SRSP
Sirius Petroleum
LSE
CPX
Cap-xx
LSE
EEE
Empire Metals
LSE
GKP
Gulf Keystone Petroleum
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved